GCVRZ - Sanofi proposes annual dividend of Euro3.76 February, 01 2024 07:55 AM Sanofi Contingent Value Right (Expiring 12/31/2020) 2024-02-01 07:55:55 ET More on Sanofi: Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 Sanofi incurs loss in Q4 amid generic competition, currency woes Sanofi Non-GAAP EPS of €1.66, revenue of €10.92B; initiates FY24 outlook For further details see: Sanofi proposes annual dividend of €3.76